OrthoPreserve

Year Founded: 2021

Team Size: 4

Location: Atlanta, GA and Richmond, VA

Artificial Meniscus Implants to Relieve Knee Pain and Protect from Arthritis

OrthoPreserve, Inc. is creating an artificial meniscus implant that will relieve chronic knee pain and prevent arthritis development for patients with knee injuries involving the meniscus. The meniscus has a critical shock absorbing function in the knee joint, but traditional treatments for a meniscus tear remove the damaged meniscus tissue, which can lead to recurring pain and accelerates joint degeneration.

OrthoPreserve’s implant mimics the natural knee tissue and replaces the damaged meniscus via a minimally invasive surgery, allowing for patients to recover quickly and return to normal activities while reducing the risk of arthritis and the need for a knee replacement. OrthoPreserve was awarded a National Institutes of Health (NIH) research grant to complete an animal study in sheep, demonstrating the implant is safe for use and protects the knee joint from degeneration.

What We’re Looking For

OrthoPreserve is seeking expertise in orthopedic FDA regulatory/clinical strategy, medical implant manufacturing, and reimbursement strategy. OrthoPreserve would also like to connect with orthopedic surgeons and orthopedic device business professionals.

Financing

  • $305,000 NIH SBIR Phase I grant
  • $2,000,000 Convertible Note Seed Round (Open)

Latest News

July 11, 2024
Tech Alum Launches Meniscus Implant Startup

Jonathan Schwartz

CEO

Inventor of implant at GA Tech; 9 Years in MedTech Engineering and Project Management

Cyrus Kump, PhD

CMO

25+ years as orthopedic surgeon specializing in knee and shoulder surgery

Max Guillot

VP

Treats 50+ patients per week in orthopedic clinic; Deep knowledge of patient/surgeon needs